METIS TECHBIO-P Opens Over 6% Higher After Lilly LNP Delivery Collaboration Worth Up to US$1.1 Billion in Milestones

Stock News10-20

METIS TECHBIO-P (07666) opened more than 6% higher, reaching HK$12.69, up 6.46%, with a turnover of HK$2.3168 million as of press time.

On the news front, on October 19, METIS TECHBIO-P announced that it has entered into a strategic collaboration with Eli Lilly to focus on novel lipid nanoparticle (LNP) delivery solutions for tissue-specific delivery of therapeutic modalities.

METIS TECHBIO-P will leverage its proprietary, AI-driven ionizable lipid discovery and optimization platform, AiLNP, to develop next-generation delivery technologies with the potential to improve LNP delivery targeting and biodistribution.

Under the terms of the agreement, METIS TECHBIO-P will receive an upfront payment of more than US$10 million and will be eligible to receive development, regulatory, and commercial milestone payments totaling up to approximately US$1.1 billion.

In addition, METIS TECHBIO-P will be eligible to receive tiered royalty payments in the single-digit percentage range based on annual net sales of products generated from the collaboration.

For more major Hong Kong stock news, download the app. For more Hong Kong and overseas wealth management information, please visit www.zhitongcaijing.com (search for "Zhitong Finance"); to join the Zhitong Hong Kong stock investment group, please add the Zhitong customer service WeChat (ztcjkf).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180425087?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-20 09:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180425087","market":"sh","top_or_hot":-1,"title":"METIS TECHBIO-P Opens Over 6% Higher After Lilly LNP Delivery Collaboration Worth Up to US$1.1 Billion in Milestones","media":"Stock News","content":"<p>METIS TECHBIO-P (07666) opened more than 6% higher, reaching HK$12.69, up 6.46%, with a turnover of HK$2.3168 million as of press time.<br><br>On the news front, on October 19, <b>METIS TECHBIO-P</b> announced that it has entered into a strategic collaboration with <b>Eli Lilly</b> to focus on novel lipid nanoparticle (LNP) delivery solutions for tissue-specific delivery of therapeutic modalities.<br><br><b>METIS TECHBIO-P</b> will leverage its proprietary, AI-driven ionizable lipid discovery and optimization platform, AiLNP, to develop next-generation delivery technologies with the potential to improve LNP delivery targeting and biodistribution.<br><br>Under the terms of the agreement, <b>METIS TECHBIO-P</b> will receive an upfront payment of more than US$10 million and will be eligible to receive development, regulatory, and commercial milestone payments totaling up to approximately US$1.1 billion.<br><br>In addition, <b>METIS TECHBIO-P</b> will be eligible to receive tiered royalty payments in the single-digit percentage range based on annual net sales of products generated from the collaboration.<br><br>For more major Hong Kong stock news, download the app. For more Hong Kong and overseas wealth management information, please visit www.zhitongcaijing.com (search for \"Zhitong Finance\"); to join the Zhitong Hong Kong stock investment group, please add the Zhitong customer service WeChat (ztcjkf).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>METIS TECHBIO-P Opens Over 6% Higher After Lilly LNP Delivery Collaboration Worth Up to US$1.1 Billion in Milestones</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMETIS TECHBIO-P Opens Over 6% Higher After Lilly LNP Delivery Collaboration Worth Up to US$1.1 Billion in Milestones\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-10-20 09:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>METIS TECHBIO-P (07666) opened more than 6% higher, reaching HK$12.69, up 6.46%, with a turnover of HK$2.3168 million as of press time.<br><br>On the news front, on October 19, <b>METIS TECHBIO-P</b> announced that it has entered into a strategic collaboration with <b>Eli Lilly</b> to focus on novel lipid nanoparticle (LNP) delivery solutions for tissue-specific delivery of therapeutic modalities.<br><br><b>METIS TECHBIO-P</b> will leverage its proprietary, AI-driven ionizable lipid discovery and optimization platform, AiLNP, to develop next-generation delivery technologies with the potential to improve LNP delivery targeting and biodistribution.<br><br>Under the terms of the agreement, <b>METIS TECHBIO-P</b> will receive an upfront payment of more than US$10 million and will be eligible to receive development, regulatory, and commercial milestone payments totaling up to approximately US$1.1 billion.<br><br>In addition, <b>METIS TECHBIO-P</b> will be eligible to receive tiered royalty payments in the single-digit percentage range based on annual net sales of products generated from the collaboration.<br><br>For more major Hong Kong stock news, download the app. For more Hong Kong and overseas wealth management information, please visit www.zhitongcaijing.com (search for \"Zhitong Finance\"); to join the Zhitong Hong Kong stock investment group, please add the Zhitong customer service WeChat (ztcjkf).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1180425087","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180425087","pubTimestamp":1792459826,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"METIS TECHBIO-P (07666) opened more than 6% higher, reaching HK$12.69, up 6.46%, with a turnover of HK$2.3168 million as of press time.On the news front, on October 19, METIS TECHBIO-P announced that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P","BK4588":"碎股","VXUS":"国际股票ETF-Vanguard","KCAI":"KraneShares China Alpha Index ETF","BK1161":"生物科技","BK4585":"ETF&股票定投概念","HK0000165453.HKD":"华夏精选大中华科技基金 A类港币"},"translate_title":"礼来 LNP 交付合作价值高达 11 亿美元，METIS TECHBIO-P 开盘上涨超过 6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"07666":1,"KCAI":1},"content_text":"METIS TECHBIO-P (07666) opened more than 6% higher, reaching HK$12.69, up 6.46%, with a turnover of HK$2.3168 million as of press time.On the news front, on October 19, METIS TECHBIO-P announced that it has entered into a strategic collaboration with Eli Lilly to focus on novel lipid nanoparticle (LNP) delivery solutions for tissue-specific delivery of therapeutic modalities.METIS TECHBIO-P will leverage its proprietary, AI-driven ionizable lipid discovery and optimization platform, AiLNP, to develop next-generation delivery technologies with the potential to improve LNP delivery targeting and biodistribution.Under the terms of the agreement, METIS TECHBIO-P will receive an upfront payment of more than US$10 million and will be eligible to receive development, regulatory, and commercial milestone payments totaling up to approximately US$1.1 billion.In addition, METIS TECHBIO-P will be eligible to receive tiered royalty payments in the single-digit percentage range based on annual net sales of products generated from the collaboration.For more major Hong Kong stock news, download the app. For more Hong Kong and overseas wealth management information, please visit www.zhitongcaijing.com (search for \"Zhitong Finance\"); to join the Zhitong Hong Kong stock investment group, please add the Zhitong customer service WeChat (ztcjkf).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180425087","isCrawlerRequest":true}